Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute –– Availability of Lunsumio VELO allows ...

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, provides an update ...

Investigator-initiated trial aims to provide proof-of-concept for bexmarilimab in overcoming acquired resistance to checkpoint inhibitors, a major challenge for most melanoma and lung cancer patients ...

MALMÖ, SE / ACCESS Newswire / December 22, 2025 / Ascelia Pharma AB (publ) (ticker:ACE)(STO:ACE) today announces that the Nomination Committee for the Annual General Meeting (AGM) on 4 May 2026 has ...

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite holding FDA Orphan Drug Designations, passing multiple DEA inspections, being awarded a DEA ...

Boards and executive buyers are raising the 2026 bar for all product and service rankings and this annual statement explains the standards Black Book applies to keep survey evaluations rigorous, ...

The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The thyroid eye disease treatments market is undergoing substantial ...

The "Narcolepsy Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior leaders in the narcolepsy treatment market face an industry defined by ...

Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...

Agreement addresses all requests by President Trump to reduce drug costs in the U.S., encourage global investment and protect ...

The "In Silico Clinical Trials Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The in silico clinical trials market is undergoing rapid transformation, ...

The "Von Willebrand Disease Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior executives navigating the rare disease pharmaceutical sector ...